Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,702 public trials 178 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase

NCT01061177

Conditions
CML in Chronic Phase, Chromosome Aberrations, Hematologic Diseases, +8 more
Locations
  • Novartis Investigative Site Wels, Austria
  • Novartis Investigative Site Graz, Austria
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
View all 320 locations
View Trial Details
Completed

Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)

NCT00880269

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Chicago Medical Center Dept. of U. of Chicago Hosp(3) Chicago, Illinois, United States
  • Nebraska Methodist Hospital Nebraska Methodist Hospital(2) Omaha, Nebraska, United States
  • North Shore University Hospital North Shore Univ Manhasset, New York, United States
  • Memorial Sloan Kettering Cancer Center Dept. of MSKCC (2) New York, United States
View all 40 locations
View Trial Details
Completed

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

NCT00786812

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Belo Horizonte, Minas Gerais, Brazil
  • Novartis Investigative Site Curitiba, Paraná, Brazil
  • Novartis Investigative Site Rio de Janeiro, Brazil
  • Novartis Investigative Site Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details
Completed

Study of the Glutaminase Inhibitor CB-839 in Leukemia

NCT02071927

Conditions
Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Tennessee Oncology, PLLC Nashville, Tennessee, United States
View Trial Details
Completed

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00002744

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Long Beach Memorial Medical Center Long Beach, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 34 locations
View Trial Details
Completed

AMG 319 Lymphoid Malignancy FIH

NCT01300026

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia, +33 more
Locations
  • Research Site Hackensack, New Jersey, United States
  • Research Site Durham, North Carolina, United States
  • Research Site Salt Lake City, Utah, United States
View Trial Details
Completed

American Ginseng in Treating Patients With Fatigue Caused by Cancer

NCT00719563

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
View all 326 locations
View Trial Details

Related conditions